Marker Therapeutics, Inc. (MRKR) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -1.4M | -1.9M | -2.74M | -1.88M | -5.5M | -4.7M | 1.2M | -3.57M | -3.84M | -2.37M | -1.13M | -7.06M | -5.89M | -6.31M | -7.65M | -794.71K | -12.23M | -4.86M | -6.52M | -6.91M |
| Operating CF Margin % | - | - | -221.9% | -218.11% | -1575.39% | -208.86% | 62.18% | -305.12% | -308.43% | -224.09% | -437.67% | -925.27% | -477.04% | -830.6% | -764.92% | -100.53% | -1267.84% | -391.24% | - | - |
| Operating CF Growth % | 74.47% | 59.6% | -328.47% | 47.35% | -43.33% | -98.65% | 206.21% | 49.44% | 34.83% | 62.45% | 85.25% | -787.95% | 51.84% | -29.79% | -17.35% | 88.5% | -35.91% | 21.88% | -53.69% | -58.8% |
| Net Income | -3.18M | -1.7M | -2M | -4.02M | -4.45M | -3.84M | -2.31M | -2.19M | -2.39M | -2.74M | -2.98M | -4.1M | -4.22M | -3.86M | -5.73M | -9.24M | -9.91M | -9.76M | -12.43M | -10.91M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 965.01K | 0 | 838.95K | 834.22K | 820.18K | 805.25K | 782.83K |
| Stock-Based Compensation | 0 | 111.13K | 33.28K | 13.99K | 379.14K | 50.54K | 53.3K | 62.6K | 79.42K | 143.37K | 175.04K | 0 | 0 | 717.17K | 0 | 0 | 1.63M | 1.47M | 1.47M | 1.65M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 178.42K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -62.94K | -260.28K | -6.12M | -2.13M | 0 | 2.73M | 1.5M | 0 | 0 | 0 | 0 |
| Working Capital Changes | 1.6M | -308.03K | -770.49K | 2.12M | -1.43M | -916.05K | 3.45M | -1.44M | -1.52M | 292.11K | 1.94M | 3.17M | 466.74K | -4.13M | -4.65M | 6.11M | -4.78M | 2.62M | 3.64M | 1.56M |
| Change in Receivables | -7.9K | 295.75K | 9.18K | 784.43K | -112.06K | -1.6M | 1.75M | 0 | -823.65K | -944.5K | 1.66M | 336.79K | 319.12K | -720.99K | -1.05M | -625.44K | -1.95K | 6 | 43 | 1M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 614.3K | -365.26K | -603.22K | 177.8K | 336.11K | -803.38K | 877.66K | -270.03K | 204.51K | 402.91K | -356.6K | 447.05K | 111.17K | 0 | 3.97M | -301.06K | -3.95M | 1.4M | 3.65M | 1.53M |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18.78M | -112.61K | -127.34K | -99.37K | -2.27M | -2.45M | -349.84K | -2M | -339.58K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 112.61K | 0 | -127.34K | 4.72M | -2.27M | -2.45M | -349.84K | -2M | -339.58K |
| CapEx % of Revenue | - | - | 0% | - | 0% | 0% | 0% | - | 0% | 0% | - | 14.77% | 0% | 16.77% | 472.05% | 286.68% | 254.29% | 28.17% | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18.66M | -112.61K | 0 | -4.82M | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 0 | 9.86M | 100 | 505 | 14.9M | 1.7K | 44.61K | 49.1K | 5.13K | 479.27K | 736 | 619.97K | 138.56K | 0 | 63.57K | 0 | 0 | 0 | -36.41K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 64.33K |
| Equity Issued (Net) | 0 | 0 | 9.86M | 100 | 505 | 14.89M | 1.7K | 36.9K | 49.1K | 5.13K | 394.67K | 736 | 619.97K | 138.56K | 0 | 63.57K | 0 | 0 | 0 | -100.74K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 3.66K | 0 | 7.7K | 0 | 0 | 84.61K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -1.4M | -1.9M | 7.13M | -1.88M | -5.5M | 10.19M | 1.2M | -3.52M | -3.79M | -2.36M | -648.19K | 11.72M | -5.38M | -6.29M | -7.75M | -3M | -14.68M | -5.21M | -8.52M | -7.29M |
| Free Cash Flow | -1.4M | -1.9M | -2.74M | -1.88M | -5.5M | -4.7M | 1.2M | -3.57M | -3.84M | -2.37M | -1.13M | -6.94M | -5.89M | -6.43M | -2.93M | -3.06M | -14.68M | -5.21M | -8.52M | -7.25M |
| FCF Margin % | - | - | -221.9% | -218.11% | -1575.39% | -208.86% | 62.18% | -305.12% | -308.44% | -224.09% | -437.67% | -910.5% | -477.04% | -847.37% | -292.88% | -387.21% | -1522.13% | -419.42% | - | - |
| FCF Growth % | 74.47% | 59.6% | -328.47% | 47.35% | -43.33% | -98.65% | 206.21% | 48.62% | 34.83% | 63.2% | 61.49% | -126.86% | 59.88% | -23.52% | 65.62% | 57.78% | -55.54% | 45.77% | -15.81% | 11.37% |
| FCF per Share | -0.07 | -0.12 | -0.16 | -0.13 | -0.50 | -0.52 | 0.13 | -0.40 | -0.43 | -0.27 | -0.13 | -0.79 | -0.68 | -0.77 | -0.35 | -0.37 | -1.77 | -0.63 | -1.03 | -0.87 |
| FCF Conversion (FCF/Net Income) | 0.44x | 1.12x | 1.37x | 0.47x | 1.24x | 1.23x | -0.52x | 1.63x | 1.60x | 0.84x | 0.38x | -2.80x | 1.19x | 1.64x | 1.10x | 0.09x | 1.23x | 0.50x | 0.52x | 0.63x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |